Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Mirvac Group (MGR.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-02-16	2.58	3.05	Buy
2022-03-08	2.41	2.70	Buy
2022-06-20	2.10	2.45	Buy
2023-01-25	2.27	2.40	Neutral
2023-02-10	2.27	2.37	Neutral
2023-06-20	2.31	2.55	Buy
2023-10-19	2.05	2.59	Buy
2023-10-26	1.88	2.48	Buy
2023-12-20	2.14	2.25	Neutral
2024-02-09	2.24	2.27	Neutral
2024-05-01	2.06	2.23	Neutral
2024-07-05	1.84	2.19	Buy
2024-08-09	1.97	2.14	Buy
2024-09-24	2.25	2.29	Neutral
2025-02-14	2.11	2.28	Neutral

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.